Chronic Granulomatous Disease (CGD): CYBB (Full Gene Sequencing)

CPT: 81479
Print Share

Test Includes

This test covers all coding nucleotides of gene CYBB, plus at least two and typically 20 flanking intronic nucleotides upstream and downstream of each coding exon, covering the conserved donor and acceptor splice sites, as well as typically 20 flanking nucleotides in the 5′ and 3′ UTR.


Special Instructions

In cases in which a known mutation can be documented, the physician may prefer to order test 252733.

Test orders must include an attestation that the provider has the patient's informed consent for genetic testing. See sample physician office consent form: Consent for Genetic Testing. In the case of family tests (ie, known mutations), please submit the result report of the first patient tested in the family (the index case), if not performed at a LabCorp facility. Other family members are subsequently tested for the specific mutation found in the first patient tested.


Expected Turnaround Time

21 - 35 days


Specimen Requirements


Specimen

Whole blood; DNA is accepted (Call 800-345-4363 for DNA collection information.)


Volume

2 mL


Container

Lavender-top (EDTA) tube


Collection

Samples may be stored for brief periods at 4°C. Ship overnight at room temperature.


Storage Instructions

Maintain specimen at room temperature.


Causes for Rejection

Container broken or leaking; container not labeled or label not legible; improper anticoagulant


Test Details


Use

Confirm a clinical diagnosis of CGD; detect carriers; allow early diagnosis in family members, guiding prophylactic measures


Limitations

This method does not reliably detect mosaic variants; large deletions; large duplications, inversions, or other rearrangements; or deep intronic variants. It may be affected by allele-dropout, it may not allow determination of the exact numbers of T/A or microsatellite repeats, and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.

Results of this test are for investigational purposes only. The performance characteristics of this assay have been determined by LabCorp. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.


Methodology

DNA sequencing


Reference Interval

Normal equals reference sequence or variants that are known or predicted to be benign; abnormal equals all other variants.


Additional Information

X-linked chronic granulomatous disease (X-CGD) is an X-linked recessive immune disorder characterized by recurrent, severe bacterial and fungal infections and chronic inflammatory granulomas. Hypergammaglobulinemia is also often observed due to persistent antigenic stimulation in response to chronic infection. X-CGD has been associated with mutations in the gene CYBB and accounts for 70% to 75% of CGD overall. Female carriers of mutations in CYBB are typically not affected by CGD, but may suffer from recurrent stomatitis or gingivitis; photosensitivity and discoid lupus erythematosus have also been observed. Genetic testing can confirm a clinical diagnosis of XLP and detect mutation carriers within affected families.


References

Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000; 79(3):170-200. 10844936
Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol. 2008; 30(3):209-235. 18509647

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
252529 CGD:CYBB 48734-8 252160 Routing 48734-8

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf